AstraZeneca’s Fasenra hit with FDA rejection, falling further behind GSK’s Nucala in nasal polyps March 14, 2022 Auto Bot News 0 AstraZeneca’s Fasenra hit with FDA rejection, falling further behind GSK’s Nucala in nasal polyps aliu Mon, 03/14/2022 – 09:22
